Endostatin fragment IV, IVox

General Information


DRACP ID  DRACP04828

Peptide Name   Endostatin fragment IV, IVox

Sequence  CETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSFMTSFSK

Sequence Length  50

UniProt ID  Not available

PubChem CID  Not available

Origin  Collagen XVIII

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C233H371N65O78S4

Absent amino acids  DP

Common amino acids  S

Mass  633331

Pl  7.18

Basic residues  5

Acidic residues  4

Hydrophobic residues  15

Net charge  1

Boman Index  -7694

Hydrophobicity  -15.2

Aliphatic Index  68.4

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  7115

Absorbance 280nm  145.2

Polar residues  23

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21470139

Title  Anti-angiogenic peptides for cancer therapeutics

Doi 10.2174/138920111796117300

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.